Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menolytin Advance
- Development stage
- Unknown
- Lead developer
- Grand Medical Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Menolytin Advance is an oral dietary supplement developed by Grand Medical Group to support women experiencing menopausal symptoms. Formulated as a mixture of standardized botanical extracts, its key ingredients include black cohosh (Cimicifuga racemosa), soy (Glycine max) isoflavones, horny goat weed (Epimedium), linseed (Linum usitatissimum), and St. John's Wort (Hypericum perforatum). These components work synergistically to provide selective estrogen receptor modulation (primarily targeting estrogen receptor beta), serotonergic activity, and anti-inflammatory effects. Menolytin Advance is approved and marketed to alleviate somatic and psychological symptoms of menopause, such as hot flashes, night sweats, anxiety, and sleep disturbances, while also helping to manage osteoporosis and prevent atherosclerosis in postmenopausal women.
- Brand names
- Menolytin Advance
- Other names
- Menolitin AdvanceMenolitin Advans
02
Targets
ESR2 (ERβ)
Beyond the preview
Go deeper on Menolytin Advance.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Menolytin Advance.